Sopris Capital Acquires Blackford Analysis from Bayer

October 9, 2026

Sopris Capital completed its acquisition of Blackford Analysis from Bayer, adding the medical-imaging AI orchestration platform to its healthcare technology portfolio. Sopris plans to combine Blackford with portfolio company Azra AI, while Blackford remains a separate legal entity and continues serving its customers; that combination was still pending at the time of the announcement.

Buyers
Sopris Capital
Targets
Blackford Analysis
Sellers
Bayer
Platforms
Azra AI
Location
Scotland, United Kingdom
Transaction Type
Addon

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.